Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...

These are the 300 companies whose success goes beyond profits to include employee and customer sentiment, cybersecurity, ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...

or Vertex Pharmaceuticals (VRTX). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own methods for finding ...

The best Shark vacuums offer a wide range of features. We tested customer favorites head-to-head; see our results and reviews ...

Arapahoe County has an adequate water supply for the foreseeable future, but needs to take conservation measures to account ...

A Bicester School Sixth Form student "rediscovered her love of learning" earlier this year following a summer internship at ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

We are thrilled to announce that Recursion is setting a new gold standard for the industry with the release of ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

Dow Jones futures will open Sunday evening, along with S&P 500 futures and Nasdaq futures, after stocks surged to record highs following Donald Trump's presidential victory.The Dow Jones and S&P 500 ...